DNA methylation and gastrointestinal malignancies: Functional consequences and clinical implications

Journal of Gastroenterology

Volumn 35, Issue 10, 2000, Pages 727-734

  Toyota, M ^a   Itoh, F ^a   Imai, K ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Methylator phenotype; Mismatch repair; Tumor suppressor gene

Indexed keywords

DNA; MICROSATELLITE DNA;

AGING; ANGIOGENESIS; APOPTOSIS; BASE MISPAIRING; CANCER INCIDENCE; CARCINOGENESIS; CELL CYCLE; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; DIGESTIVE SYSTEM CANCER; DNA METHYLATION; DNA REPAIR; DNA SEQUENCE; GENE MUTATION; GENE SILENCING; GROWTH REGULATION; HUMAN; HUMAN TISSUE; MICROSATELLITE INSTABILITY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SEQUENCE HOMOLOGY; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

DNA; DNA METHYLATION; GASTROINTESTINAL NEOPLASMS; GENES, SUPPRESSOR; HUMANS;

EID: 0033762469     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350070030     Document Type: Review

References (47)

1. Transcription of IAP endogenous retroviruses is constrained by cytosine methylation
2. Number of CpG islands and genes in human and mouse
3. Hypomethylation distinguishes genes of some human cancers from their normal counterparts
4. DNA methylation and genetic instability in colorectal cancer cells
5. DNA hypomethylation leads to elevated mutation rates
6. Cancer epigenetics comes of age
7. Alterations in DNA methylation: A fundamental aspect of neoplasia
8. Methylation of the estrogen receptor CpG island in lung tumors is related to the specific type of carcinogen exposure
9. A berrant CpG-island methylation has non-random and tumour-type-specific patterns
10. Identification and characterization of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR
11. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification
12. Inactivation of CACNA1G, a T-type calcium channel gene, by aberrant methylation of its 5' CpG island in human tumors
13. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development
14. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene
15. Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis
16. CpG Island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression
17. Methylation-induced repression-belts, braces, and chromatin
18. Identification and characterization of a family of mammalian methyl-CpG binding proteins
19. A mammalian protein with specific demethylase activity for mCpG DNA
20. The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites
21. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription
22. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex
23. MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex
24. Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation
25. Overexpression of the MTA1 gene in gastrointestinal carcinomas: Correlation with invasion and metastasis
26. Molecular cloning, mapping, and characterization of a novel human gene, MTA1-L1, showing homology to a metastasis-associated gene, MTA1
27. Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status
28. Distinct methylation pattern and microsatellite instability in sporadic gastric cancer
29. Aberrant DNA methylation precedes loss of heterozygosity on chromosome 16 in chronic hepatitis and liver cirrhosis
30. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon
31. CpG island methylator phenotype in colorectal cancer
32. Lessons from hereditary colorectal cancer
33. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability
34. Association between CpG island methylation and microsatellite instability in colorectal cancer
35. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma
36. DNA methylator and mismatch repair phenotypes are not mutually exclusive in colorectal cancer cell lines
37. Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype
38. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype
39. Hypermethylation of multiple genes in pancreatic carcinoma
40. Methylation profiling in acute myeloid leukemia
41. Methylation profiling of CpG islands in human breast cancer cells
42. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients
43. Quantitative analysis of aberrant p16 methylation using real-time quantitative methylation-specific polymerase chain reaction
44. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia
45. Cellular differentiation, cytidine analogs and DNA methylation
46. Low-Dose 5-aza-2'-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: A multicenter phase II study in elderly patients
47. Synergy of demethylation and histone deacetylase inhibition in the reexpression of genes silenced in cancer